For the quarter ending 2025-09-30, LFMDP had -$11,219,153 decrease in cash & cash equivalents over the period. $9,845,484 in free cash flow.
| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -4,323,177 |
| Amortization of debt discount | 234,369 |
| Amortization of capitalized software | 7,087,054 |
| Amortization of intangibles | 775,338 |
| Loss on debt extinguishment | -1,155,851 |
| Depreciation of fixed assets | 609,569 |
| Noncash operating lease expense | 821,604 |
| Stock compensation expense | 7,841,178 |
| Accounts receivable | -1,609,763 |
| Product deposit | 329,755 |
| Inventory | 635,024 |
| Other current assets | 580,382 |
| Operating lease liabilities | -248,574 |
| Deferred revenue | -5,270,408 |
| Accounts payable | 3,545,251 |
| Accrued expenses | -731,959 |
| Net cash provided by operating activities | 11,560,698 |
| Cash paid for capitalized software costs | 8,446,187 |
| Purchase of equipment | 1,715,214 |
| Net cash used in investing activities | -10,161,401 |
| Repayment of debt instruments | 18,719,721 |
| Sale of common stock under atm, net | 8,721,717 |
| Preferred stock dividends | 2,329,688 |
| Cash proceeds from exercise of warrants | 464,950 |
| Cash proceeds from exercise of options | 5,950 |
| Distributions to non-controlling interest | 761,658 |
| Net cash used in financing activities | -12,618,450 |
| Net (decrease) increase in cash | -11,219,153 |
| Cash and cash equivalents at beginning of period | 35,004,924 |
| Cash and cash equivalents at end of period | 23,785,771 |
LifeMD, Inc. (LFMDP)
LifeMD, Inc. (LFMDP)